AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Clover Health Q2 Earnings Beat Estimates, Stock Drops Despite Strong Growth
ByAinvest
Thursday, Aug 7, 2025 6:16 am ET1min read
Clover Health Investments Corp. (CLOV) reported Q2 revenue of $477.62 million, up 34% YoY, beating estimates. The company's adjusted net loss was two cents per share, better than the expected loss of three cents per share. CLOV stock is down 9.86% in after-hours trading.
Clover Health Investments Corp. (CLOV), a health insurance company, reported its Q2 2025 earnings, with revenue surging 34% year-over-year (YoY) to $477.6 million, beating Wall Street estimates by 1.7% [1]. The company's adjusted net loss of $0.02 per share was better than the expected loss of $0.03 per share, aligning with analysts' consensus estimates [1].Key highlights from the Q2 2025 results include:
- Revenue Growth: Clover Health's revenue increased by 34.1% YoY, reaching $477.6 million, which exceeded analysts' estimates of $469.5 million [1].
- Earnings Per Share (EPS): The company reported an adjusted EPS of $0.02 per share, which was better than the expected loss of $0.03 per share [1].
- Segmental Details: Insurance revenues totaled $469.8 million, up 34.3% YoY, driven by a 32% increase in Medicare Advantage membership [3].
- Operational Metrics: Total operating expenses increased by 39.9% YoY, and the company's net medical claims rose by 52.2% YoY [3].
- Financial Position: Clover Health exited Q2 2025 with $188.6 million in cash and cash equivalents [3].
- Guidance: The company expects 2025 Insurance revenues to be in the range of $1.8-$1.875 billion, suggesting 37% YoY growth at the midpoint [3].
CLOV stock is down 9.86% in after-hours trading following the earnings report. The decline in share price can be attributed to rising medical cost ratios (BER) stemming from elevated Part D utilization and higher supplemental benefits costs, particularly in dental [3]. Despite the mixed performance, the company emphasized its progress in sustaining adjusted EBITDA profitability and delivering robust membership and revenue growth within Medicare Advantage.
References:
[1] https://finance.yahoo.com/news/clover-health-nasdaq-clov-beats-215512917.html
[2] https://www.marketscreener.com/news/earnings-flash-clov-clover-health-investments-corp-reports-q2-revenue-477-6m-vs-factset-est-o-ce7c5ed8df8ef324
[3] https://finance.yahoo.com/news/clov-q2-earnings-line-stock-143900176.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet